Although evidence-based intensive care medicine is gradually developing, progress in clinical trials has been hampered by the small number of patients, broad range of diagnostic categories, and lack of diagnostic criteria and illness severity measures.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Department of Critical Care Medicine, Royal Hobart Hospital, Hobart, TAS.
Correspondence: anthony.bell@dchs.tas.gov.au
- 1. Hillman KM, Bristow PJ, Chey T, et al. Antecedents to hospital deaths. Intern Med J 2001; 31: 343-348.
- 2. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
- 3. Bellomo R, Chapman M, Finfer S, et al, for the Australian and New Zealand Intensive Care Society Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 2000; 356: 2139-2143.
- 4. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
- 5. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
Online responses are no longer available. Please refer to our instructions for authors page for more information.